$SNSS Viracta Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Viracta Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Viracta Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Viracta Therapeutics, Inc. for free.
CIK Number: 0001061027
IRS Number: 943295878
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: SNSS
Company Address: 2533 S COAST HWY 101 SUITE 210 CARDIFF 92007
Phone number: 650-266-3500
Former name: MOSAIC PHARMACEUTICALS INC, date of change: 1998-07-09
Former name: SUNESIS PHARMACEUTICALS INC, date of change: 1998-05-01
Market Capitalization: $85.18M
Prev close: $4.10
Average Daily Volume: 44,423
Days Low: $4.05
Year Low: $2.63
Year High: $6.30
Viracta Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | SNSS | Viracta Therapeuti ... | Rojkjaer Lisa | Chief Medical Offic ... | Option Exercise | M | 3.58 | 2,061 | 7,378 | 30,956 | |
May 13 2021 | SNSS | Viracta Therapeuti ... | Rojkjaer Lisa | Chief Medical Offic ... | Option Exercise | M | 1.26 | 32,689 | 41,188 | 98,069 | |
May 13 2021 | SNSS | Viracta Therapeuti ... | Rojkjaer Lisa | Chief Medical Offic ... | Buy | M | 3.58 | 2,061 | 7,378 | 34,750 | 32.7 K to 34.8 K (+6.30 %) |
May 13 2021 | SNSS | Viracta Therapeuti ... | Rojkjaer Lisa | Chief Medical Offic ... | Buy | M | 1.26 | 32,689 | 41,188 | 32,689 | 0 to 32.7 K |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | Rojkjaer Lisa | Chief Medical Offic ... | Option Exercise | A | 8.74 | 126,890 | 1,109,019 | 126,890 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | ONETTO NICOLE | Director | Option Exercise | A | 8.74 | 80,000 | 699,200 | 80,000 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | Huang Michael | Director | Option Exercise | A | 8.74 | 80,000 | 699,200 | 80,000 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | Simon Barry J. | Director | Option Exercise | A | 8.74 | 80,000 | 699,200 | 80,000 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | Roshwalb Gur | Director | Option Exercise | A | 8.74 | 80,000 | 699,200 | 80,000 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | DARCY THOMAS E | Director | Option Exercise | A | 8.74 | 80,000 | 699,200 | 80,000 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | Murphy Samuel Lafayette | Director | Option Exercise | A | 8.74 | 80,000 | 699,200 | 80,000 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | Pomerantz Roger | Director | Option Exercise | A | 8.74 | 135,000 | 1,179,900 | 135,000 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | Rubino Stephen | Director | Option Exercise | A | 8.74 | 80,000 | 699,200 | 80,000 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | ROYSTON IVOR | CEO & President | Option Exercise | A | 8.74 | 441,993 | 3,863,019 | 441,993 | |
Mar 30 2021 | SNSS | Viracta Therapeuti ... | Chevallard Daniel R. | CFO and COO | Option Exercise | A | 8.74 | 78,912 | 689,691 | 78,912 |